{"abstract": "Biogen says its partner, Elan, has violated their deal to share ownership of the drug Tysabri. Elan says it has not.", "web_url": "https://www.nytimes.com/2009/08/07/business/07drug.html", "snippet": "Biogen says its partner, Elan, has violated their deal to share ownership of the drug Tysabri. Elan says it has not.", "lead_paragraph": "Two longtime biotechnology partners, Biogen Idec and Elan, are fighting over the rights to their big-selling multiple sclerosis drug Tysabri. ", "print_section": "B", "print_page": "5", "source": "The New York Times", "multimedia": [], "headline": {"main": "Partners Behind an MS Drug Take Their Dispute to Court", "kicker": null, "content_kicker": null, "print_headline": "Partners Behind an MS Drug Take Their Dispute to Court", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Biogen Idec Incorporated", "rank": 1, "major": "N"}, {"name": "persons", "value": "Icahn, Carl C", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Elan Corporation PLC", "rank": 4, "major": "N"}, {"name": "subject", "value": "Multiple Sclerosis", "rank": 5, "major": "N"}, {"name": "subject", "value": "Biotechnology", "rank": 6, "major": "N"}], "pub_date": "2009-08-06T22:56:44+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/d49b867e-8c49-53b5-abec-769f07cd2ad0", "word_count": 501, "uri": "nyt://article/d49b867e-8c49-53b5-abec-769f07cd2ad0"}